ArticleThe lancet. Healthy longevity2022

Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England.

Maria Krutikov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.